Studies have shown that LSD1 is closely correlated with cell proliferation, angiogenesis, migration and invasion in prostate cancer [61,62,63,64], including castrate-resistant prostate cancer (CRPC), which is characterized by resistance to androgen-deprivation therapy (ADT) [65]. Here, KDM1A is linked to prostate cancer.